Report Detail
Global Oral Solid Dosage Pharmaceutical Formulation Market Insights, Forecast to 2025
- RnM2716913 |
- 11 June, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Oral solid dosage forms are the most commonly used pharmaceuticals to treat various disease conditions. Oral solid dosage forms are cost-effective and easy to manufacture in comparison with other dosage forms. They offer significant benefits to manufacturers such as trouble free packaging and transportation and increased chemical and physical stability. Oral solids offer many advantages to patients as well.
North America dominated the global oral solid dosage pharmaceutical formulation market in revenue terms in 2017, and the trend is projected to continue throughout the forecast period.
The global Oral Solid Dosage Pharmaceutical Formulation market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oral Solid Dosage Pharmaceutical Formulation market based on company, product type, end user and key regions.
This report studies the global market size of Oral Solid Dosage Pharmaceutical Formulation in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oral Solid Dosage Pharmaceutical Formulation in these regions.
This research report categorizes the global Oral Solid Dosage Pharmaceutical Formulation market by top players/brands, region, type and end user. This report also studies the global Oral Solid Dosage Pharmaceutical Formulation market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Gilead
Merck
Novartis
Pfizer
AbbVie
Boehringer Ingelheim
Market size by Product
Immediate Release
Extended Release
Others
Market size by End User
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Oral Solid Dosage Pharmaceutical Formulation market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Oral Solid Dosage Pharmaceutical Formulation market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Oral Solid Dosage Pharmaceutical Formulation companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Oral Solid Dosage Pharmaceutical Formulation submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Oral Solid Dosage Pharmaceutical Formulation are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oral Solid Dosage Pharmaceutical Formulation market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Oral Solid Dosage Pharmaceutical Formulation Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Product
- 1.4.2 Immediate Release
- 1.4.3 Extended Release
- 1.4.4 Others
- 1.5 Market by End User
- 1.5.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by End User
- 1.5.2 Hospital Pharmacy
- 1.5.3 Retail Pharmacy
- 1.5.4 Drug Stores
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size
- 2.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Revenue 2014-2025
- 2.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Sales 2014-2025
- 2.2 Oral Solid Dosage Pharmaceutical Formulation Growth Rate by Regions
- 2.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales by Regions
- 2.2.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Oral Solid Dosage Pharmaceutical Formulation Sales by Manufacturers
- 3.1.1 Oral Solid Dosage Pharmaceutical Formulation Sales by Manufacturers
- 3.1.2 Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Manufacturers
- 3.1.3 Global Oral Solid Dosage Pharmaceutical Formulation Market Concentration Ratio (CR5 and HHI)
- 3.2 Oral Solid Dosage Pharmaceutical Formulation Revenue by Manufacturers
- 3.2.1 Oral Solid Dosage Pharmaceutical Formulation Revenue by Manufacturers (2014-2019)
- 3.2.2 Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Manufacturers (2014-2019)
- 3.3 Oral Solid Dosage Pharmaceutical Formulation Price by Manufacturers
- 3.4 Oral Solid Dosage Pharmaceutical Formulation Manufacturing Base Distribution, Product Types
- 3.4.1 Oral Solid Dosage Pharmaceutical Formulation Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Oral Solid Dosage Pharmaceutical Formulation Product Type
- 3.4.3 Date of International Manufacturers Enter into Oral Solid Dosage Pharmaceutical Formulation Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales by Product
- 4.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Product
- 4.3 Oral Solid Dosage Pharmaceutical Formulation Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by End User
6 North America
- 6.1 North America Oral Solid Dosage Pharmaceutical Formulation by Countries
- 6.1.1 North America Oral Solid Dosage Pharmaceutical Formulation Sales by Countries
- 6.1.2 North America Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Oral Solid Dosage Pharmaceutical Formulation by Product
- 6.3 North America Oral Solid Dosage Pharmaceutical Formulation by End User
7 Europe
- 7.1 Europe Oral Solid Dosage Pharmaceutical Formulation by Countries
- 7.1.1 Europe Oral Solid Dosage Pharmaceutical Formulation Sales by Countries
- 7.1.2 Europe Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Oral Solid Dosage Pharmaceutical Formulation by Product
- 7.3 Europe Oral Solid Dosage Pharmaceutical Formulation by End User
8 Asia Pacific
- 8.1 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation by Countries
- 8.1.1 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Sales by Countries
- 8.1.2 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation by Product
- 8.3 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation by End User
9 Central & South America
- 9.1 Central & South America Oral Solid Dosage Pharmaceutical Formulation by Countries
- 9.1.1 Central & South America Oral Solid Dosage Pharmaceutical Formulation Sales by Countries
- 9.1.2 Central & South America Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Oral Solid Dosage Pharmaceutical Formulation by Product
- 9.3 Central & South America Oral Solid Dosage Pharmaceutical Formulation by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation by Countries
- 10.1.1 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales by Countries
- 10.1.2 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation by Product
- 10.3 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation by End User
11 Company Profiles
- 11.1 AstraZeneca
- 11.1.1 AstraZeneca Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Products Offered
- 11.1.5 AstraZeneca Recent Development
- 11.2 Bristol-Myers Squibb
- 11.2.1 Bristol-Myers Squibb Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Products Offered
- 11.2.5 Bristol-Myers Squibb Recent Development
- 11.3 Eli Lilly
- 11.3.1 Eli Lilly Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Products Offered
- 11.3.5 Eli Lilly Recent Development
- 11.4 Gilead
- 11.4.1 Gilead Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Gilead Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Gilead Oral Solid Dosage Pharmaceutical Formulation Products Offered
- 11.4.5 Gilead Recent Development
- 11.5 Merck
- 11.5.1 Merck Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Merck Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Merck Oral Solid Dosage Pharmaceutical Formulation Products Offered
- 11.5.5 Merck Recent Development
- 11.6 Novartis
- 11.6.1 Novartis Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Novartis Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Novartis Oral Solid Dosage Pharmaceutical Formulation Products Offered
- 11.6.5 Novartis Recent Development
- 11.7 Pfizer
- 11.7.1 Pfizer Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Pfizer Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Pfizer Oral Solid Dosage Pharmaceutical Formulation Products Offered
- 11.7.5 Pfizer Recent Development
- 11.8 AbbVie
- 11.8.1 AbbVie Company Details
- 11.8.2 Company Business Overview
- 11.8.3 AbbVie Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 AbbVie Oral Solid Dosage Pharmaceutical Formulation Products Offered
- 11.8.5 AbbVie Recent Development
- 11.9 Boehringer Ingelheim
- 11.9.1 Boehringer Ingelheim Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Products Offered
- 11.9.5 Boehringer Ingelheim Recent Development
12 Future Forecast
- 12.1 Oral Solid Dosage Pharmaceutical Formulation Market Forecast by Regions
- 12.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Regions 2019-2025
- 12.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Regions 2019-2025
- 12.2 Oral Solid Dosage Pharmaceutical Formulation Market Forecast by Product
- 12.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Product 2019-2025
- 12.2.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Product 2019-2025
- 12.3 Oral Solid Dosage Pharmaceutical Formulation Market Forecast by End User
- 12.4 North America Oral Solid Dosage Pharmaceutical Formulation Forecast
- 12.5 Europe Oral Solid Dosage Pharmaceutical Formulation Forecast
- 12.6 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Forecast
- 12.7 Central & South America Oral Solid Dosage Pharmaceutical Formulation Forecast
- 12.8 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Oral Solid Dosage Pharmaceutical Formulation Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Oral Solid Dosage Pharmaceutical Formulation . Industry analysis & Market Report on Oral Solid Dosage Pharmaceutical Formulation is a syndicated market report, published as Global Oral Solid Dosage Pharmaceutical Formulation Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Oral Solid Dosage Pharmaceutical Formulation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
